Kindler HL - Search Results

1

Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.

Kratzke RA, Wang X, Wong L, Kratzke MG, Green MR, Vokes EE, Vogelzang NJ, Kindler HL, Kern JA; Cancer and Leukemia Group B. Kratzke RA, et al. Among authors: kindler hl. J Thorac Oncol. 2008 Apr;3(4):417-21. doi: 10.1097/JTO.0b013e318168da0a. J Thorac Oncol. 2008. PMID: 18379362 Free article.

2

Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B.

Kindler HL, Belani CP, Herndon JE 2nd, Vogelzang NJ, Suzuki Y, Green MR. Kindler HL, et al. Cancer. 1999 Nov 15;86(10):1985-91. Cancer. 1999. PMID: 10570422 Clinical Trial.

3

Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B.

Kindler HL, Millard F, Herndon JE 2nd, Vogelzang NJ, Suzuki Y, Green MR. Kindler HL, et al. Lung Cancer. 2001 Feb-Mar;31(2-3):311-7. doi: 10.1016/s0169-5002(00)00166-5. Lung Cancer. 2001. PMID: 11165412 Clinical Trial.

4

High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study-Cancer and Leukemia Group B 9631.

Kosty MP, Herndon JE 2nd, Vogelzang NJ, Kindler HL, Green MR. Kosty MP, et al. Among authors: kindler hl. Lung Cancer. 2001 Nov;34(2):289-95. doi: 10.1016/s0169-5002(01)00250-1. Lung Cancer. 2001. PMID: 11679188 Clinical Trial.

5

Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.

Schilsky RL, Bertucci D, Vogelzang NJ, Kindler HL, Ratain MJ. Schilsky RL, et al. Among authors: kindler hl. J Clin Oncol. 2002 Jan 15;20(2):582-7. doi: 10.1200/JCO.2002.20.2.582. J Clin Oncol. 2002. PMID: 11786589 Clinical Trial.

6

The role of gemcitabine in the treatment of malignant mesothelioma.

Kindler HL, van Meerbeeck JP. Kindler HL, et al. Semin Oncol. 2002 Feb;29(1):70-6. doi: 10.1053/sonc.2002.30232. Semin Oncol. 2002. PMID: 11836671 Review.

7

Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.

Akerley W, Herndon JE, Egorin MJ, Lyss AP, Kindler HL, Savarese DM, Sherman CA, Rosen DM, Hollis D, Ratain MJ, Green MR. Akerley W, et al. Among authors: kindler hl. Cancer. 2003 May 15;97(10):2480-6. doi: 10.1002/cncr.11375. Cancer. 2003. PMID: 12733147 Free article. Clinical Trial.

8

Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).

Otterson GA, Herndon JE 2nd, Watson D, Green MR, Kindler HL; Cancer and Leukemia Group B. Otterson GA, et al. Among authors: kindler hl. Lung Cancer. 2004 May;44(2):251-9. doi: 10.1016/j.lungcan.2003.10.011. Lung Cancer. 2004. PMID: 15084390 Clinical Trial.

9

9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium.

Kindler HL, Avadhani A, Wade-Oliver K, Karrison T, Mani S, Vokes EE. Kindler HL, et al. Invest New Drugs. 2004 Aug;22(3):323-7. doi: 10.1023/B:DRUG.0000026259.28395.c2. Invest New Drugs. 2004. PMID: 15122080 Clinical Trial.

10

A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer.

Eng C, Kindler HL, Nattam S, Ansari RH, Kasza K, Wade-Oliver K, Vokes EE. Eng C, et al. Among authors: kindler hl. Ann Oncol. 2004 Jun;15(6):928-32. doi: 10.1093/annonc/mdh236. Ann Oncol. 2004. PMID: 15151950 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters